Contribution to the Study of Diabetic Kidney Disease in a Sub-Saharan Environment: An Example of the Aristide Le Dantec University Hospital in Dakar
- 1 Nephrology Department, Aristide Le Dantec University Hospital, Dakar, Senegal
- 2 Nephrology Department, Aristide Le Dantec University Hospital, Dakar, Senegal
- 3 Nephrology Department, Dalal Jamm National Hospital Center, Dakar, Senegal
- 4 Nephrology Department, Aristide Le Dantec University Hospital, Dakar, Senegal
- 5 Nephrology Department, Aristide Le Dantec University Hospital, Dakar, Senegal
- 6 Nephrology Department, Aristide Le Dantec University Hospital, Dakar, Senegal
- 7 Nephrology Department, Dalal Jamm National Hospital Center, Dakar, Senegal
- 8 Nephrology Department, Aristide Le Dantec University Hospital, Dakar, Senegal
Abstract
Introduction: Diabetic kidney disease (DKD) is a leading cause of chronic kidney disease and dialysis admission. Few studies are available in Sub-Saharan Africa. The objective of this work was to study the epidemiological, clinical, diagnostic and therapeutic characteristics of DKD in our context. Patients and Methods: We conducted an observational, exhaustive and retrospective study focusing on diabetic patients seen in consultation or hospitalized in the Nephrology Department of at the Aristide Le Dantec University Hospital in Dakar during a period of 5 years from January 1, 2017 to December 31, 2021. Results: Of 4735 patients seen during the study period, 491 had DKD, i.e. a hospital prevalence of 10.36%. The average age was 59.1 ± 11.4 years with a sex ratio of 0.95. Type 2 diabetes predominated with 93.4%. The average duration of diabetes was 11.5 ± 7.6 years. Diabetes was associated with high blood pressure in 78.81% of cases, dyslipidemia in 23.2% of cases, active smoking in 6.7% of cases and obesity in 1.6% of cases. Renal failure was the main reason for referral 72.3%. One hundred and forty-eight patients (30.1%) had uncontrolled diabetes. Macroalbuminuria was found in 64.8% and microalbuminuria in 18.7% of cases. One hundred and eighty-five patients (37.7%) were in Stage V of kidney disease and 137 patients were in Stage III (18.1% in Stage IIIb and 9.8% in Stage IIIa). Diabetic nephropathy was the main etiology at 61.30%. Nephropathy was mixed (diabetic and hypertensive) in 18.12 cases. Renin-angiotensin-aldosterone system (RAAS) blockers were prescribed in 83.5% of patients. Conclusion: The different etiologies encountered during the study show the diversity of diabetic kidney disease. Diabetic nephropathy is not the only kidney damage that can occur in diabetics in our context.
- Chen, Y., Lee, K., Ni, Z. and He, J.C. (2020) Diabetic Kidney Disease: Challenges, Advances, and Opportunities. Kidney Disease, 6, 215-225. https://doi.org/10.1159/000506634
- Espinel, E., Agraz, I., Ibernon, M., et al. (2015) Renal Biopsy in Type 2 Diabetic Patients. Journal of Clinical Medicine, 4, 998-1009. https://doi.org/10.3390/jcm4050998
- Rezaianzadeh, A., Namayandeh, S.M. and Sadr, S.M. (2012) National Cholesterol Education Program Adult Treatment Panel III versus International Diabetic Federation Definition of Metabolic Syndrome, Which One Is Associated with Diabetes Mellitus and Coronary Artery Disease? International Journal of Preventive Medicine, 3, 552-558.
- Gariani, K., De Seigneux, S., Martin, P.Y., Pechère-Bertschi, A. and Philippe, J. (2012) Néphropathie diabétique. Revue Médicale Suisse, 8, 473-479.
- World Health Organization (WHO) (2021) On the Frontlines of Diabetes Fight in Senegal. https://www.afro.who.int/news/frontlines-diabetes-fight-senegal
- Ould Isselmoi, E.B., Abdou, N., Abdoulaye, L., et al. (2010) Aspect épidémiologique, et diagnostique de la néphropathies chez le diabétique: étude rétrospective. Diabetes & Metabolism, 36, A48. https://doi.org/10.1016/S1262-3636(10)70183-X
- Wild, S., Roglic, G., Green, A., et al. (2004) Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030. Diabetes Care, 27, 1047-1053. https://doi.org/10.2337/diacare.27.5.1047
- Bailey, R.A., Wang, Y., Zhu, V. and Rupnow, M.F. (2014) Chronic Kidney Disease in US Adults with Type 2 Diabetes: An Updated National Estimate of Prevalence Based on Kidney Disease: Improving Global Outcomes (KDIGO) Staging. BMC Research Notes, 7, Article No. 415. https://doi.org/10.1186/1756-0500-7-415
- United States Renal Data System (USRDS) (2017) International Comparisons. https://www.usrds.org/2017/view/v2_11.aspx
- Boright, A.P., Paterson, A.D., Mirea, L., et al. (2005) Genetic Variation at the ACE Gene Is Associated with Persistent Microalbuminuria and Severe Nephropathy in Type 1 Diabetes: The DCCT/EDIC Genetic Study. Diabetes, 54, 1238-1244. https://doi.org/10.2337/diabetes.54.4.1238
- Marre, M., Jeunemaitre, X., Gallois, Y., et al. (1997) Contribution of Genetic Polymorphism in the Renin-Angiotensin System to the Development of Renal Complications in Insulin-Dependent Diabetes. Journal of Clinical Investigation, 99, 1585-1595. https://doi.org/10.1172/JCI119321